ANGELOS HALARIS: Open Payments
NPI 1891762621 · MAYWOOD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$698 in 17 payments from 11 companies in 2025. Trend: 2023 $780 · 2024 $1,059 · 2025 $698
Food & beverage: $698
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $301 |
| ABBVIE INC. | 1 | $91 |
| Alkermes, Inc. | 1 | $90 |
| Neurocrine BioSciences, Inc. | 2 | $51 |
| TMS NeuroHealth Centers Inc. | 1 | $34 |
| Janssen Scientific Affairs, LLC | 1 | $26 |
| Corium, LLC | 1 | $25 |
| Tris Pharma Inc | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
Products named: CAPLYTA, VRAYLAR, ARISTADA, INGREZZA, SPRAVATO, TMS NeuroHealth Centers Inc., Azstarys, Dyanavel XR.
Industry payments across IL — which companies pay providers there.
